Skip to main content

WORKING AT
THE EDGE OF
IMPOSIBLE  

TO HELP DELIVER
BREAKTHROUGH
CELL & GENE
THERAPIES

 

WELCOME TO OXGENE

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics.

Our discovery technologies help pioneers advance their CAR-T, CRISPR, capsid or promoter discovery programmes. Our biomanufacturing solutions further accelerate the development and scalable manufacture of lentiviral, AAV or adenoviral vector based therapeutics.

Our pioneering spirit fuels us; we're open minded, collaborative, responsive and ambitious. We push the boundaries of possibility to drive breakthrough therapeutics from laboratory research all the way to clinical manufacture.

By combining WuXi ATU's world class cell and gene therapy CTDMO platform with OXGENE's innovative capabilities, we will be able to provide transformative solutions for our customers.

DAVID CHANG, CEO, WUXI ADVANCED THERAPIES

 

Dr Ryan Cawood

Chief Scientific Officer,
OXGENE and WuXi ATU

OUR MISSION IS TO
ACCELERATE SUCCESS

TECHNOLOGY AT THE
EDGE OF IMPOSSIBLE

Based in Oxford, UK, we help cell and gene therapy pioneers accelerate development of their breakthrough therapeutics.
 

Leadership

Careers

Then and Now: Interview with Ryan Cawood

Our Awards

Our pioneering spirit drives our success. We're honoured to be recognised in the following awards.

BE FIRST in the race to deliver
breakthrough Cell & Gene Therapies

Are you ready for GMP Manufacture?

WuXi Advanced Therapies is a global Contract Testing, Development
and Manufacturing Organization (CTDMO) dedicated to accelerating
progress and time to market for cell and gene therapies.

×